PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy
- 3 October 2007
- journal article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 44 (6), 972-981
- https://doi.org/10.1016/j.freeradbiomed.2007.09.013
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Nitric Oxide and Peroxynitrite in Health and DiseasePhysiological Reviews, 2007
- Effects of poly(ADP-ribose) polymerase inhibition on dysfunction of non-adrenergic non-cholinergic neurotransmission in gastric fundus in diabetic ratsNitric Oxide, 2006
- The Leptin-Deficient (ob/ob) MouseDiabetes, 2006
- Poly(ADP-ribose) (PAR) polymer is a death signalProceedings of the National Academy of Sciences, 2006
- Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesisBiochemical and Biophysical Research Communications, 2006
- Poly(ADP-Ribose) Polymerase Inhibitors Ameliorate Nephropathy of Type 2 Diabetic Leprdb/dbMiceDiabetes, 2006
- Inhibition of poly(ADP‐ribose) polymerase prevents irinotecan‐induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinomaThe FASEB Journal, 2006
- Poly(ADP-Ribose) Polymerase Inhibition Alleviates Experimental Diabetic Sensory NeuropathyDiabetes, 2006
- Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetesCurrent Opinion in Pharmacology, 2006
- Role of Poly(ADP-Ribose) Polymerase-1 Activation in the Pathogenesis of Diabetic Complications: Endothelial Dysfunction, as a Common Underlying ThemeAntioxidants and Redox Signaling, 2005